Solventum (SOLV) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Insiders put their own money in: $100K of open-market buys. See how similar setups did below.
Past insider buys here: 1 of 1 beat the S&P 500 over the next 90 days (small sample). See each one ↓
Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Purchase Amy McBride Wendell, Director bought 1,475 shares at $68.03 ($100K).
- Trade date
- Mar 10, 2026
- Disclosed to the SEC
- Mar 11, 2026
- Type
- Open-market purchase (code P)
Amy McBride Wendell's record since 2023: 1 of 1 past buy beat the S&P 500 over 90 days (small sample).
Read the original SEC filing ↗All SOLV insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
SOLV insider transactions (Form 4)
Open-market purchases and sales. 64 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 11SEC | Amy McBride WendellDirectorFirst buy | Buy | 1,4755,039 held (+41%) | $68.03 | $100K | +25.7% | — |
Similar past setups: not applicable. There aren't enough comparable past cases for SOLV's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with SOLV in the Research Lab
Pre-set to SOLV's latest insider buy of $10K or more (Mar 11, 2026: Amy McBride Wendell, $100K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Solventum insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $100K and 0 sold $0 of SOLV stock on the open market; P/E 99.8 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
SOLV insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $100K | 1 | — | 0 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 Solventum insider reported open-market purchases totaling $100K, while 0 insiders reported sales totaling $0.
SOLV earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 5, 2026 | +11.0% | None | -5.7%S&P -0.4% | +10.5% |
| May 5, 2026 | -4.3% | None | +5.3%S&P +2.2% | +14.1% |
| Feb 26, 2026 | -6.7% | None | -1.2%S&P -1.0% | -15.4% |
| Nov 6, 2025 | -7.2% | None | +5.7%S&P -1.0% | +19.4% |
| Aug 7, 2025 | -0.5% | None | +1.1%S&P +0.7% | -0.9% |
| May 8, 2025 | +0.8% | None | +7.2%S&P +0.6% | +6.6% |
| Feb 27, 2025 | +14.1% | None | -5.1%S&P -0.1% | -6.3% |
| Nov 7, 2024 | +2.1% | None | -2.3%S&P +1.2% | -3.4% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
SOLV short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded SOLV
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Thomas H TubervilleSenate | Sold $1,001 - $15,000 | May 3, 2024 | Aug 5, 2026 | +32.2% |
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +36.2% |
What happened after SOLV insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Mar 11, 2026 | Amy McBride WendellDirector | $100K | -0.8%+1.4% vs S&P | -2.7%-3.4% vs S&P | +21.9%+12.7% vs S&P |
Insiders at Solventum
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Amy McBride WendellDirector | $100K | — | May 1, 2026 | 1 of 1 | — |
| Heather KnightChief Commercial Officer | — | — | Nov 19, 2026 | — | — |
| Bryan C. HansonCEO | — | — | Sep 3, 2026 | — | — |
| Wayde D. McMillanCFO | — | — | May 15, 2026 | — | — |
| Amy LanducciChief Information Officer | — | — | May 15, 2026 | — | — |
| Marcela A. KirbergerGeneral Counsel | — | — | May 15, 2026 | — | — |
| Paul S. HarringtonChief Supply Chain Officer | — | — | May 15, 2026 | — | — |
| Tammy L. GomezChief Human Resources Officer | — | — | May 15, 2026 | — | — |
| Mary T. WilcoxChief Accounting Officer | — | — | May 15, 2026 | — | — |
| Carrie Smith CoxDirector | — | — | May 1, 2026 | — | — |
| Karen J. MayDirector | — | — | May 1, 2026 | — | — |
| John H. WeilandDirector | — | — | May 1, 2026 | — | — |
| Glenn A. EisenbergDirector | — | — | May 1, 2026 | — | — |
| Bernard A. Harris Jr.Director | — | — | May 1, 2026 | — | — |
| Carlos AlbanDirector | — | — | May 1, 2026 | — | — |
| Susan D. DevoreDirector | — | — | May 1, 2026 | — | — |
| Darryl L. WilsonDirector | — | — | May 1, 2026 | — | — |
| Elizabeth MilyDirector | — | — | May 1, 2026 | — | — |
| Shirley Ann EdwardsDirector | — | — | May 1, 2026 | — | — |
Board links: companies that share insiders with SOLV
Directors and executives who filed Form 4s for SOLV and another company in the last 12 months.
- AXGNAxogen Amy McBride Wendell Director here · Director at AXGN · latest filing Aug 12, 2026
- BAXBaxter International Amy McBride Wendell Director here · Director at BAX · latest filing May 7, 2026
- ELVElevance Health Susan D. Devore Director here · Director at ELV · latest filing May 15, 2026
- ETNEaton Darryl L. Wilson Director here · Director at ETN · latest filing May 8, 2026
- NEENextEra Energy Darryl L. Wilson Director here · Director at NEE · latest filing May 1, 2026
- OGNOrganon Carrie Smith Cox Director here · Chair at OGN · latest filing May 1, 2026
- TXNTexas Instruments Carrie Smith Cox Director here · Director at TXN · latest filing May 14, 2026
- WATWaters Heather Knight Chief Commercial Officer here · Director at WAT · latest filing Nov 19, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
SOLV stock: common questions
Are Solventum insiders buying SOLV stock?
In the past 12 months, 1 insider reported open-market purchases of SOLV worth $100K. The latest was Director Amy Mcbride Wendell bought $100K of SOLV at $68.03 — first open-market purchase in our records; raises the stake by 41%.
Are Solventum insiders selling SOLV stock?
No. No Solventum insider reported an open-market sale of SOLV in the past 12 months.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is SOLV's P/E ratio?
SOLV trades at about 99.8 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is SOLV's 52-week range?
Over the past year SOLV has traded between $62.49 and $92.44. It last closed at $85.49 on Nov 19, 2026.